Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,485 across all filing types
Latest filing 2019-05-02 Earnings Release
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Earnings Release 2019
Earnings Release Classification · 100% confidence The document is explicitly titled 'Coloplast announcement no. 04/2019 - Interim Financial Report, H1 2018/19' and contains detailed financial performance metrics (organic growth, revenue, EBIT, ROIC) for the first six months (H1 2018/19). This content aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it contains highlights similar to an Earnings Release (ER), the depth of the financial data and the explicit mention of 'Interim financial report' strongly suggest the comprehensive report itself, rather than just the initial press release summary. The document length (4416 chars) is substantial enough to be the report summary or the report itself, but the content is clearly focused on the period's financial results. H1 2019
2019-05-02 English
Earnings Release 2019
Earnings Release Classification · 100% confidence The document is titled "Coloplast selskabsmeddelelse nr. 04/2019 - Regnskabsmeddelelse, H1 2018/19" and contains detailed financial results for the first half (H1) of the fiscal year 2018/19 (October 1, 2018 - March 31, 2019). It includes key metrics like organic revenue growth, EBIT, ROIC, dividend declaration, and updated financial guidance for the full year. This content structure strongly indicates a comprehensive financial report for a period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is a press release announcing the results, the core content provided is the summary of the financial report itself, making IR a better fit than RPA or ER, which are typically shorter highlights or announcements of publication timing. Since it covers a half-year period, it is classified as IR. H1 2019
2019-05-02 Danish
Coloplast announcement no. 04/2019 - Interim Financial Report, H1 2018/19
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half (H1) of the 2018/19 fiscal year for Coloplast A/S. It includes detailed financial statements, key performance indicators (KPIs), management commentary on business segments (Stomi, Kontinens, Urologi, Hud- og Sårpleje), and regional performance analysis. Since it covers a period shorter than a full fiscal year and contains substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2019
2019-05-02 Danish
Coloplast announcement no. 04/2019 - Interim Financial Report, H1 2018/19
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive interim financial report for Coloplast for the first half (H1) of the 2018/19 fiscal year. It includes detailed financial highlights, key ratios, management's report on sales performance by business area and region, and unaudited financial statements. It is not a mere announcement (RPA) as it contains substantive financial data and analysis, nor is it a full annual report (10-K). Therefore, it fits the definition of an Interim/Quarterly Report. H1 2019
2019-05-02 English
Share buy-back week 17/2019
Transaction in Own Shares Classification · 100% confidence The document contains detailed transactional data related to Coloplast A/S's share buyback program for a specific week in April 2019. It includes dates, quantities, prices, and total amounts of shares repurchased. The text references compliance with EU regulations on share buybacks and stabilization mechanisms. There is no indication of financial statements, earnings data, management commentary, or other report types. The content is focused solely on the company's repurchase of its own shares, which fits the definition of a Transaction in Own Shares (POS) filing. The document length is substantial and contains detailed transaction logs, confirming it is not a mere announcement but a report of share repurchase activity.
2019-04-29 English
Share buy-back week 17/2019
Transaction in Own Shares Classification · 100% confidence The document is a corporate announcement from Coloplast detailing specific transactions made under an existing share buyback program. It lists the number of shares purchased, the purchase price, and the total amount spent over a specific period (April 23-26, 2019). This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2019-04-29 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.